Molecule intelOpportunity: Moderate0

Multiple Vitamins

74 brands · 53 companies · product forms

5 DRAP alerts

Opportunity snapshot

Launch attractiveness

39

Market saturation

85

Price room

59

Regulatory risk

90

74

brands

53

companies

Rs 500

median price

3

price points

3.35x

price spread

90

confidence %

Who competes here

Top companies by brand count — fragmented market (no dominant player) · leader share 5%

ENGLISH PHARMACEUTICALS INDUSTRIES

4 brands · 5%

EVEREST PHARMACEUTICALS

3 brands · 4%

3 brands · 4%

XENON PHARMACEUTICALS (PVT) LTD.

3 brands · 4%

HASSAN PHARMACEUTICALS (PVT) LTD.

2 brands · 3%

MILLINIUM PHARMACEUTICAL COMPANY

2 brands · 3%

SAMI PHARMACEUTICALS (PVT) LTD.

2 brands · 3%

Pfizer Laboratories (Pvt) Ltd.

2 brands · 3%

HIMONT PHARMACEUTICALS (PVT) LTD.

2 brands · 3%

ZAM ZAM CORPORATION

2 brands · 3%

Price room

Across observed sources and strengths

CheapestRs 294.5

MedianRs 500

Most expensiveRs 987.1

Spread3.35×

Sources: DVAGO

max/min price ratio 3.35x across 3 trusted points (Rs 294.5-987.1). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Brands & products on the market

Sample of 3 live products for Multiple Vitamins — each links to its own medicine page.

HIMONT PHARMACEUTICALS (PVT) LTD.

Rs 294.5

SEARLE PAKISTAN (PVT.) LTD.

Rs 474.9

HIMONT PHARMACEUTICALS (PVT) LTD.

Rs 987.1

Regulatory alerts

Shortage exposureRecall exposureSafety exposurelatest 2026-04-30

Recall Alert: Drug Product; Water for Injection (Batch #M21421) by M/s. Vision Pharmaceuti

The National Pharmacovigilance Center, DRAP urge the manufacturers and importers to nomina

Rapid Alert: Drug Product Recall: Incidents of loss and damage of vision with the off-labe

Directive on the security of online portals and engagement with authorized personnel/consu

Drug Safety Alert: Risk of Reduced Vitamin B12 Level with Metformin and Metformin-Containi

Why this score

Launch attractiveness

40% supply-gap(20) + 25% price-variation(59) + 20% low-competition(15) + 15% supply-disruption(100), damped by confidence(90). Higher = more attractive, less crowded opportunity.

Market saturation

53 canonical companies and 74 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 3.35x across 3 trusted points (Rs 294.5-987.1). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

5 DRAP alert(s), latest 2026-04-30 incl. recall/safety.

Confidence

Reduced by: no ATC code.

Packaged brief for this moderate opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules